Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Mads Nybo"'
Autor:
Michael S Hansen, Jordi S. Dahl, Lene Svendstrup Christensen, Tine J Philippsen, Axel Brandes, Mads Nybo
Publikováno v:
Philippsen, T J, Christensen, L S, Nybo, M, Hansen, M S, Dahl, J S & Brandes, A 2022, ' Circulating biomarkers, echocardiographic parameters, and incident subclinical atrial fibrillation in patients with diabetes and hypertension ', Pacing and Clinical Electrophysiology, vol. 45, no. 1, pp. 35-42 . https://doi.org/10.1111/pace.14399
BACKGROUND: Long-term rhythm monitoring (LTRM) can detect undiagnosed atrial fibrillation (AF) in patients at high risk of AF and stroke. Biomarkers and echocardiographic parameters could, however, help identify patients benefitting most from LTRM. T
Publikováno v:
Nybo, M, Fruekilde, P N & Andersen-Ranberg, K 2021, ' Measurement of vitamin D in dried blood spots stored under different temperature conditions ', Annals of Clinical Biochemistry, vol. 58, no. 5, pp. 461-467 . https://doi.org/10.1177/00045632211013870
Background As part of the Survey of Health, Ageing and Retirement in Europe (SHARE) study, dried blood spot samples were obtained for measurement of potential biological biomarkers, among those vitamin D. Unfortunately, no studies describe the impact
Autor:
Annette Kjær Ersbøll, Simone Møller Hede, Mogens Lytken Larsen, Mads Nybo, Anders Green, Marie Skov Kristensen, Gunnar Gislason, Kristian Handberg Mikkelsen
Publikováno v:
BMC Cardiovascular Disorders, Vol 20, Iss 1, Pp 1-11 (2020)
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : a Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, no. 1, 336 . https://doi.org/10.1186/s12872-020-01616-9
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : A Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, 336 . https://doi.org/10.1186/s12872-020-01616-9
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : a Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, 336 . https://doi.org/10.1186/s12872-020-01616-9
BMC Cardiovascular Disorders
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : a Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, no. 1, 336 . https://doi.org/10.1186/s12872-020-01616-9
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : A Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, 336 . https://doi.org/10.1186/s12872-020-01616-9
Kristensen, M S, Green, A, Nybo, M, Hede, S M, Mikkelsen, K H, Gislason, G, Larsen, M L & Ersbøll, A K 2020, ' Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome : a Danish population-based cohort study ', BMC Cardiovascular Disorders, vol. 20, 336 . https://doi.org/10.1186/s12872-020-01616-9
BMC Cardiovascular Disorders
Background Patients with acute coronary syndrome (ACS) are at high risk of recurrent cardiovascular (CV) event. The European guidelines recommend low-density lipoprotein cholesterol (LDL-C) levels In order to reduce the risk of further cardiac events
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 11 (2021)
Siersbæk, J, Larsen, A R, Nybo, M & Christesen, H T 2021, ' A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism ', Frontiers in Endocrinology, vol. 11, 614993 . https://doi.org/10.3389/fendo.2020.614993
Frontiers in Endocrinology, Vol 11 (2021)
Siersbæk, J, Larsen, A R, Nybo, M & Christesen, H T 2021, ' A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism ', Frontiers in Endocrinology, vol. 11, 614993 . https://doi.org/10.3389/fendo.2020.614993
BackgroundThe diagnosis of congenital hyperinsulinism (CHI) may be hampered by a plasma (p-) insulin detection limit of 12–18 pmol/L (2–3 mU/L).ObjectiveTo evaluate the diagnostic performance of a sensitive insulin immunoassay and to find the opt
Publikováno v:
Sejbaek, T, Nybo, M, Petersen, T & Illes, Z 2018, ' Real-life persistence and tolerability with dimethyl fumarate ', Multiple Sclerosis and Related Disorders, vol. 24, pp. 42-46 . https://doi.org/10.1016/j.msard.2018.05.007
BACKGROUND: Dimethyl fumarate (DMF) has been registered for the treatment of relapsing-remitting multiple sclerosis (RRMS). Differences in tolerability between multiple sclerosis clinics in patients treated with DMF has not been examined.AIM: We exam
Publikováno v:
Gils, C, Sandberg, M B & Nybo, M 2020, ' Verification of the hemolysis index measurement : imprecision, accuracy, measuring range, reference interval and impact of implementing analytically and clinically derived sample rejection criteria ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 80, no. 7, pp. 580-589 . https://doi.org/10.1080/00365513.2020.1818281
Automated spectrophotometric measurement of hemolysis index (HI) allows rapid and cost-effective assessment of hemolysis interference. We evaluated the analytical performance of HI on two different platforms. Further, the impact of implementing analy
Autor:
Daniel Prieto-Alhambra, Bo Abrahamsen, Alexander J. Rodríguez, Anne Pernille Hermann, Peter R. Ebeling, Martin Ernst, Mads Nybo
Publikováno v:
Rodriguez, A J, Ernst, M T, Nybo, M, Prieto-Alhambra, D, Ebeling, P R, Hermann, A P & Abrahamsen, B 2020, ' Oral bisphosphonate use reduces cardiovascular events in a cohort of Danish patients referred for bone mineral density ', The Journal of clinical endocrinology and metabolism, vol. 105, no. 10, dgaa481, pp. 3215-3225 . https://doi.org/10.1210/clinem/dgaa481
Context The cardiovascular (CV) safety of oral bisphosphonates (oBPs) is uncertain. Objective Determine the risk of CV events in oBP users referred for bone mineral density (BMD) testing compared with matched controls. Design Cohort study. Setting Da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::517fd9c06f8ee1ebd9414dc61edd99f9
https://doi.org/10.1210/clinem/dgaa481
https://doi.org/10.1210/clinem/dgaa481
Autor:
Axel Cosmus Pyndt Diederichsen, Søren Bak, Kenneth Bruun Pedersen, Mads Nybo, Niels C F Sandgaard, Axel Brandes, Charlotte Madsen
Publikováno v:
Pedersen, K B, Madsen, C, Sandgaard, N C F, Diederichsen, A C P, Bak, S, Nybo, M & Brandes, A 2020, ' Predictive Markers of Atrial Fibrillation in Patients with Transient Ischemic Attack ', Journal of Stroke & Cerebrovascular Diseases, vol. 29, no. 4, 104643 . https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104643
BACKGROUND: Atrial fibrillation (AF) is a major cause of cardio-embolism in patients with stroke and transient ischemic attack (TIA). Insertable cardiac monitors (ICM) make long-term monitoring for AF possible, but limited health care resources make
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0204a31fa2241ba60e27054f547cbdee
https://portal.findresearcher.sdu.dk/da/publications/5b4e1ccd-2ed3-4442-9b76-9f8c98d2826c
https://portal.findresearcher.sdu.dk/da/publications/5b4e1ccd-2ed3-4442-9b76-9f8c98d2826c
Autor:
Anne-Mette Hvas, Kåre Hornbech, Nora E. Zois, Henrik Vad, Mads Nybo, S. Pedersen, Peter B. Licht, Thomas Christensen
Publikováno v:
Hvas, A-M, Vad, H, Pedersen, S, Licht, P B, Nybo, M, Hornbech, K, Zois, N E & Christensen, T D 2019, ' Platelet function in lung cancer patients undergoing lobectomy ', Scandinavian Journal of Clinical and Laboratory Investigation, vol. 79, no. 7, pp. 513-518 . https://doi.org/10.1080/00365513.2019.1663555
Hvas, A-M, Vad, H, Pedersen, S, Licht, P B, Nybo, M, Hornbech, K, Zois, N E & Christensen, T D 2019, ' Platelet function in lung cancer patients undergoing lobectomy ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 79, no. 7, pp. 513-518 . https://doi.org/10.1080/00365513.2019.1663555
Hvas, A-M, Vad, H, Pedersen, S, Licht, P B, Nybo, M, Hornbech, K, Zois, N E & Christensen, T D 2019, ' Platelet function in lung cancer patients undergoing lobectomy ', Scandinavian Journal of Clinical & Laboratory Investigation, vol. 79, no. 7, pp. 513-518 . https://doi.org/10.1080/00365513.2019.1663555
A growing interest concerns arterial thromboembolic disease in cancer patients. As platelets may be key players in this process, investigation of platelet aggregation in cancer patients is of importance. We aimed to investigate platelet aggregation i
Autor:
Rasmus Søgaard Hansen, Mads Nybo
Publikováno v:
Hansen, R S & Nybo, M 2019, ' The association between activated protein C ratio and Factor V Leiden are gender-dependent ', Clinical Chemistry and Laboratory Medicine, vol. 57, no. 8, pp. 1229-1234 . https://doi.org/10.1515/cclm-2018-1382
Background The most common cause of activated protein C (aPC) resistance is a missense substitution (Arg506Gln), known as Factor V Leiden (FVL). Due to its low cost, many laboratories use the aPC ratio as a primary test with a unisex cut-off. However
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::052ead663b476364ef4fb961b08feac7
https://findresearcher.sdu.dk:8443/ws/files/149509248/The_association_between_activated_protein_C_ratio_and_Factor_V_Leiden_are_gender_dependent.pdf
https://findresearcher.sdu.dk:8443/ws/files/149509248/The_association_between_activated_protein_C_ratio_and_Factor_V_Leiden_are_gender_dependent.pdf